Reply

Emily D Bethea^{1

2

3}, Qiushi Chen^{1

2}, Chin Hur^{1

2

3}, Raymond T Chung^{2

3}, Jagpreet Chhatwal^{1

2

3}

Affiliations

¹ Massachusetts General Hospital Institute for Technology Assessment, Boston, MA.
² Harvard Medical School, Boston, MA.
³ Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.

Comment

Emily D Bethea et al. Hepatology. 2018 Apr.

. 2018 Apr;67(4):1641-1642.

doi: 10.1002/hep.29770. Epub 2018 Feb 27.

Emily D Bethea^{1

2

3}, Qiushi Chen^{1

2}, Chin Hur^{1

2

3}, Raymond T Chung^{2

3}, Jagpreet Chhatwal^{1

2

3}

¹ Massachusetts General Hospital Institute for Technology Assessment, Boston, MA.
² Harvard Medical School, Boston, MA.
³ Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.

No abstract available

Comment on

Should we treat acute hepatitis C? A decision and cost-effectiveness analysis.
Bethea ED, Chen Q, Hur C, Chung RT, Chhatwal J. Bethea ED, et al. Hepatology. 2018 Mar;67(3):837-846. doi: 10.1002/hep.29611. Epub 2018 Jan 24. Hepatology. 2018. PMID: 29059461 Free PMC article.
Treatment of acute hepatitis C virus is cost-effective but at what price?
Congly SE, Lee SS. Congly SE, et al. Hepatology. 2018 Apr;67(4):1640-1641. doi: 10.1002/hep.29771. Epub 2018 Feb 28. Hepatology. 2018. PMID: 29315682 No abstract available.